Copeland Capital Management, LLC Eli Lilly & CO Transaction History

Copeland Capital Management, LLC

$5.61 Billion
Q3 2024

A detailed history of Copeland Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Copeland Capital Management, LLC holds 25,369 shares of LLY stock, worth $19 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

25,369

Previous 26,363 3.77%

Holding current value

$19 Million

Previous $23.9 Million 5.84%

% of portfolio

0.4%

Previous 0.46%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$772.14 - $960.02 $767,507 - $954,259	-994 Reduced 3.77%	25,369 $22.5 Million
Q2 2024 Jul 26, 2024	BUY	$724.87 - $909.04 $642,234 - $805,409	886 Added 3.48%	26,363 $23.9 Million
Q1 2024 Apr 19, 2024	BUY	$592.2 - $792.28 $1.13 Million - $1.51 Million	1,900 Added 8.06%	25,477 $19.8 Million
Q4 2023 Jan 19, 2024	BUY	$525.19 - $619.13 $4.89 Million - $5.77 Million	9,318 Added 65.35%	23,577 $13.7 Million
Q3 2023 Oct 23, 2023	SELL	$434.7 - $599.3 $147,798 - $203,761	-340 Reduced 2.33%	14,259 $7.66 Million
Q2 2023 Jul 14, 2023	BUY	$350.74 - $468.98 $4.64 Million - $6.2 Million	13,217 Added 956.37%	14,599 $6.85 Million
Q1 2020 Jan 18, 2022	BUY	$119.05 - $147.35 $164,527 - $203,637	1,382 New	1,382 $192,000
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $164,527 - $203,637	-1,382 Closed	0 $0
Q4 2019 Jan 18, 2022	BUY	$106.92 - $132.43 $147,763 - $183,018	1,382 New	1,382 $182,000
Q4 2019 Feb 03, 2020	SELL	$106.92 - $132.43 $147,763 - $183,018	-1,382 Closed	0 $0
Q3 2019 Jan 18, 2022	BUY	$106.79 - $116.16 $147,583 - $160,533	1,382 New	1,382 $155,000
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $147,583 - $160,533	-1,382 Closed	0 $0
Q2 2019 Jan 18, 2022	BUY	$110.79 - $129.32 $153,111 - $178,720	1,382 New	1,382 $153,000
Q2 2019 Jul 19, 2019	SELL	$110.79 - $129.32 $153,111 - $178,720	-1,382 Closed	0 $0
Q1 2019 Jan 18, 2022	BUY	$111.31 - $131.02 $153,830 - $181,069	1,382 New	1,382 $179,000
Q1 2019 Apr 24, 2019	SELL	$111.31 - $131.02 $178,096 - $209,632	-1,600 Closed	0 $0
Q4 2018 Jan 18, 2022	BUY	$105.9 - $118.64 $169,440 - $189,824	1,600 New	1,600 $185,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copeland Capital Management, LLC with notifications on news.

Account

Copeland Capital Management, LLC Eli Lilly & CO Transaction History